News Center
NEWS
Qingsong Health's QSevidence partners with China Academy of Chinese Medical Sciences to build an intelligent research support platform
Recently, the Artemisinin Research Center of the China Academy of Chinese Medical Sciences partnered with Qingsong Health's QSevidence to build a traditional Chinese medicine (TCM) intelligent platform. Based on their respective foundations in TCM research and medical AI, the two parties will collaborate on TCM intelligent data processing, research knowledge organization, research support tools, and technology transfer.
QSevidence and the Five-Step Process of Evidence-Based Medicine: A Framework for
This article outlines the five-step process of evidence-based medicine—formulating clinical questions, efficiently searching for evidence, critically appraising evidence, assessing applicability, and evaluating the results of application—and explores how the QSevidence platform leverages AI technology to assist physicians in rapidly accessing high-quality medical evidence and enhancing the efficiency of clinical decision-making.
Qingsong Health recognized as a 2026 AIGC company to watch; QSevidence named a product to watch.
At the 4th China AIGC Industry Summit, Qingsong Health received enterprise-level recognition for AI and health innovation, while QSevidence was selected as a notable AIGC product in medical AI.
Qingsong Health joins the China Pharmaceutical Industry Chamber of Commerce as an executive council member.
The appointment recognizes Qingsong Health's capabilities across digital health services, AI medical innovation, pharmaceutical collaboration and industry ecosystem development.
Qingsong Health and Hubei Chinese Online partner to build a traceable AI medical data foundation.
The collaboration focuses on high-quality medical data resources, evidence-based medicine and large-model technology to strengthen traceability, transparency and compliance for medical AI.
Qingsong Health proposes health judgment infrastructure at the 2026 China Internet Development Symposium.
Chairwoman and CEO Yang Yin called for evidence-based AI to help turn health anxiety into clearer judgment, professional information into action paths and episodic care into continuous management.
Hong Kong Chief Executive John Lee visits Qingsong Health's tech exhibition, focusing on AI evidence-based medicine and early screening.
Qingsong Health presented QSevidence MedClaw and its early-disease screening portfolio at the 2026 World Internet Conference Asia-Pacific Summit in Hong Kong.
Qingsong Health launches the medical industry's first Skill Store: QSevidence MedClaw Skills Store.
The first release introduced 886 standardized skills across clinical diagnosis and treatment, public health, imaging, laboratory medicine, hospital management, nursing, medical records and medication management.
QSevidence MedClaw connects evidence-based medical intelligence with OpenClaw multi-agent capabilities.
The MedClaw collaboration body combines evidence retrieval, guideline comparison, credibility grading, task planning, content generation and process records into one traceable workflow.